Sepsis Recognition and the Sepsis Bundle

Definitions and Bedside Identification of Sepsis and Septic Shock

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. When circulatory and cellular metabolic abnormalities become severe enough to substantially increase mortality, the condition progresses to septic shock. Clinically, septic shock is defined as sepsis with persistent hypotension requiring vasopressors to maintain a mean arterial pressure of 65 mmHg or greater and a serum lactate greater than 2 mmol/L despite adequate fluid resuscitation.

Early recognition relies on structured screening tools. Systemic Inflammatory Response Syndrome (SIRS) criteria include a core temperature greater than 38 degrees Celsius or less than 36 degrees Celsius, tachycardia greater than 90 beats per minute, a respiratory rate greater than 20 breaths per minute or a PaCO2 less than 32 mmHg, and a white blood cell count greater than 12,000 cells/mcL, less than 4,000 cells/mcL, or greater than 10 percent immature band forms. Meeting two or more SIRS criteria in the setting of suspected infection provides nonspecific warning signs that warrant prompt assessment for acute organ dysfunction and rapid escalation under sepsis screening protocols.

To establish acute organ dysfunction related to infection, clinicians assess the Sequential Organ Failure Assessment (SOFA) score. The SOFA score systematically evaluates respiratory, coagulation, hepatic, cardiovascular, neurological, and renal organ systems, where an acute increase in the total score of 2 points or more identifies infection-related organ dysfunction. At the bedside, the quick SOFA (qSOFA) tool offers a rapid assessment using three clinical criteria: a respiratory rate of 22 breaths per minute or greater, altered mentation, and a systolic blood pressure of 100 mmHg or less. Regardless of the scoring tool used, new or worsening tachypnea serves as an early, nonspecific bedside warning sign of possible sepsis-related deterioration.

Bedside physical presentations can vary markedly between patients. A hyperdynamic, or 'warm,' septic shock phenotype can include flushed skin, bounding pulses, a widened pulse pressure, and low systemic vascular resistance. Conversely, another patient may present with cool, mottled extremities, delayed capillary refill, and weak pulses. These physical signs reflect differences in vascular tone and perfusion, but they do not establish a fixed stage of shock or reliably define elevated systemic vascular resistance.

Surviving Sepsis Campaign Hour-1 Bundle Interventions

The Surviving Sepsis Campaign Hour-1 Bundle emphasizes immediate action upon the recognition of sepsis or septic shock. An initial blood lactate measurement must be drawn immediately at recognition. If this initial lactate exceeds 2 mmol/L, follow the sepsis protocol for repeat measurement, commonly within 2 to 4 hours, and interpret the trend alongside other perfusion findings. A lactate level of 4 mmol/L or greater also serves as an explicit trigger requiring immediate resuscitation with intravenous fluids.

Diagnostic blood cultures must be collected before antimicrobial therapy whenever collection will not substantially delay administration. When feasible, collect at least two blood culture sets, each containing aerobic and anaerobic bottles, from separate peripheral venipuncture sites. If a catheter-related bloodstream infection is suspected, obtain ordered paired blood culture sets from both the central catheter and a peripheral venipuncture site, regardless of how long the catheter has been in place. If cultures prove difficult to obtain, escalate promptly and do not substantially delay antimicrobial administration.

Timely antimicrobial delivery is vital for patient survival. For patients with possible septic shock or a high likelihood of sepsis, administer prescribed intravenous antimicrobials immediately, ideally within 1 hour of recognition. For patients with possible sepsis without shock, conduct a prompt clinical assessment and administer prescribed antimicrobials within 3 hours if infection remains likely. Critical care nurses exercise clinical judgment under approved protocols to ensure these time-sensitive medications are infused without unnecessary barrier delays.

Fluid Resuscitation Strategies and Crystalloid Selection

For adult patients presenting with sepsis-induced hypoperfusion or septic shock, administer the ordered initial fluid resuscitation of at least 30 mL/kg of intravenous crystalloid within 3 hours. A serum lactate of 4 mmol/L or greater independently triggers this 30 mL/kg fluid administration. While infusing these fluids, the critical care nurse must frequently reassess the patient for improvements in systemic perfusion and monitor closely for signs of fluid intolerance.

Fluid selection directly impacts patient outcomes. Balanced crystalloids, such as lactated Ringer solution, are preferred over 0.9 percent normal saline to minimize the risk of hyperchloremic metabolic acidosis. In contrast, artificial colloids must be strictly avoided: do not use hydroxyethyl starches because of increased risks of kidney injury, renal replacement therapy, and death. Avoid gelatin for sepsis resuscitation, and recognize that dextrans are generally not used due to adverse effects, including coagulation and renal complications.

After large-volume crystalloid resuscitation, the healthcare provider may consider intravenous albumin if further volume expansion is needed. Throughout any ongoing fluid administration, the nurse must continually reassess for tissue perfusion and monitor for fluid overload. Excessive fluid administration leads to severe complications, including acute respiratory distress syndrome, acute kidney injury, and increased mortality, underscoring the necessity of transitioning away from fixed fluid protocols toward individualized assessments.

Vasoactive Medications and Hemodynamic Support

In septic shock, initiate ordered vasopressors promptly when hypotension persists during initial fluid resuscitation; do not wait for the full fluid volume to be infused before addressing severe hypotension. Norepinephrine is the first-line vasopressor for restoring vascular tone in septic shock. The critical care nurse titrates norepinephrine within the provider order or approved protocol toward an initial mean arterial pressure target of at least 65 mmHg while continuously assessing the patient's overall perfusion. To facilitate prompt initiation, peripheral intravenous vasopressor administration is acceptable as a short-term bridging measure through a proximal vein while central venous access is secured.

If mean arterial pressure remains inadequate or if norepinephrine requirements are elevated, secondary agents may be added. Vasopressin at a fixed dosage of 0.03 units per minute can be added to norepinephrine to raise mean arterial pressure or reduce norepinephrine requirements. In septic shock, vasopressin is commonly prescribed at this fixed infusion rate rather than titrated to blood pressure; nurses must follow the provider order and local facility protocol. If the combination of norepinephrine and vasopressin fails to achieve the target mean arterial pressure, epinephrine is recommended as an additional agent.

Other vasoactive medications have narrow, specific roles. Norepinephrine is preferred over dopamine; the provider may consider dopamine in select patients with a low risk of tachyarrhythmias and clinically important absolute or relative bradycardia. Phenylephrine is generally not a first-line vasopressor for septic shock, though the provider may consider it in select circumstances such as clinically significant tachyarrhythmias occurring with catecholamine vasopressors. For septic shock with cardiac dysfunction and persistent hypoperfusion despite adequate fluid resuscitation and arterial pressure, the provider may add dobutamine to norepinephrine or choose epinephrine.

For patients experiencing septic shock with an ongoing vasopressor requirement despite fluid resuscitation, the provider may order intravenous hydrocortisone at 200 mg/day, requiring the nurse to monitor closely for adverse effects such as hyperglycemia. For any patient requiring continuous vasopressor infusions, the nurse should advocate for arterial catheter blood pressure monitoring as soon as practical when appropriate and available, utilizing frequent noninvasive blood pressure measurements until arterial access is established.

Hemodynamic Monitoring, Perfusion Endpoints, and the AACN Synergy Model

Assessing fluid responsiveness is essential to prevent both hypoperfusion and dangerous hypervolemia. Fluid responsiveness is defined as a 10 to 15 percent increase in stroke volume or cardiac output following a volume challenge. Dynamic measures of fluid responsiveness are superior to static parameters, such as central venous pressure, for guiding fluid administration. One validated dynamic approach is the passive leg raise test, which temporarily shifts approximately 300 to 500 mL of endogenous venous blood into the central circulation to assess preload responsiveness. Nurses must assess the effect of a passive leg raise with a rapid measure of stroke volume or cardiac output, such as echocardiography or pulse-contour monitoring, rather than relying on blood pressure changes alone.

Heart-lung interactions provide additional dynamic indices, but they carry strict operational limitations. Stroke volume variation (SVV) and pulse pressure variation (PPV) are most reliable during controlled mechanical ventilation without spontaneous breathing efforts, with a regular cardiac rhythm and adequate tidal volume, and in the absence of major confounders such as right ventricular dysfunction. In patients managed with lung-protective tidal volumes near 6 mL/kg of predicted body weight, SVV and PPV may be unreliable; in this setting, the nurse should consider other dynamic assessments rather than increasing tidal volumes solely to meet a fixed monitoring threshold.

Bedside tissue perfusion must be continuously triangulated using clinical endpoints. Capillary refill time is an effective, noninvasive bedside endpoint for monitoring peripheral tissue perfusion during shock resuscitation. A capillary refill time longer than about 3 seconds can suggest impaired peripheral perfusion, though it must be interpreted alongside temperature, vasopressor use, and other clinical findings. Tracking urine output, using at least 0.5 mL/kg/h as one indicator of renal perfusion, is also essential while interpreting the trend alongside kidney function and overall perfusion. Serial lactate measurements are tracked over time; while a decreasing lactate level can suggest improving perfusion, it must be evaluated alongside other findings because elevated lactate is not specific to tissue hypoxia alone.

Central venous oxygen saturation (ScvO2) reflects the balance between systemic oxygen delivery and systemic oxygen consumption. A value below approximately 70% may prompt further assessment; however, targeting an ScvO2 of at least 70% is not a routine contemporary sepsis-bundle endpoint. Furthermore, an abnormally elevated ScvO2 exceeding 85 percent in septic shock can reflect impaired cellular oxygen extraction and microvascular shunting rather than adequate tissue oxygenation. Under the AACN Synergy Model, optimal outcomes occur when critical care nurses match their clinical competencies to the high acuity and vulnerability of unstable septic patients, recognizing physiological deterioration, activating rapid response systems, and executing bundle protocols with precision.